Search Results - "Chikhale, Rupesh V"

Refine Results
  1. 1

    Unlocking the potential of PROTACs: A comprehensive review of protein degradation strategies in disease therapy by Bhole, Ritesh P., Kute, Payal R., Chikhale, Rupesh V., Bonde, C.G., Pant, Amit, Gurav, Shailendra S.

    Published in Bioorganic chemistry (01-10-2023)
    “…[Display omitted] •PROTACs (PROteolysis TArgeting Chimeras) are a technology used for protein degradation through the use of bifunctional small molecules.•They…”
    Get full text
    Journal Article
  2. 2

    Identification of sugar-containing natural products that interact with i-motif DNA by Chikhale, Rupesh V., Guneri, Dilek, Yuan, Robert, Morris, Christopher J., Waller, Zoë A.E.

    Published in Bioorganic & medicinal chemistry letters (01-10-2022)
    “…[Display omitted] There are thousands of compounds shown to interact with G-quadruplex DNA, yet very few which target i-motif (iM) DNA. Previous work showed…”
    Get full text
    Journal Article
  3. 3

    A Review on Five and Six-Membered Heterocyclic Compounds Targeting the Penicillin-Binding Protein 2 (PBP2A) of Methicillin-Resistant Staphylococcus aureus (MRSA) by Ambade, Shraddha S., Gupta, Vivek Kumar, Bhole, Ritesh P., Khedekar, Pramod B., Chikhale, Rupesh V.

    Published in Molecules (Basel, Switzerland) (10-10-2023)
    “…Staphylococcus aureus is a common human pathogen. Methicillin-resistant Staphylococcus aureus (MRSA) infections pose significant and challenging therapeutic…”
    Get full text
    Journal Article
  4. 4

    Structural insights into i-motif DNA structures in sequences from the insulin-linked polymorphic region by Guneri, Dilek, Alexandrou, Effrosyni, El Omari, Kamel, Dvořáková, Zuzana, Chikhale, Rupesh V., Pike, Daniel T. S., Waudby, Christopher A., Morris, Christopher J., Haider, Shozeb, Parkinson, Gary N., Waller, Zoë A. E.

    Published in Nature communications (20-08-2024)
    “…The insulin-linked polymorphic region is a variable number of tandem repeats region of DNA in the promoter of the insulin gene that regulates transcription of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives by Bhole, Ritesh P., Chikhale, Rupesh V., Rathi, Karishma M.

    Published in IBRO neuroscience reports (01-06-2024)
    “…Alzheimer's disease (AD), a progressive degenerative disorder first identified by Alois Alzheimer in 1907, poses a significant public health challenge. Despite…”
    Get full text
    Journal Article
  7. 7

    Identification of Mycobacterium tuberculosis transcriptional repressor EthR inhibitors: Shape-based search and machine learning studies by Chikhale, Rupesh V., Eldesoky, Gaber E., Kolpe, Mahima Sudhir, Suryawanshi, Vikramsinh Sardarsinh, Patil, Pritee Chunarkar, Bhowmick, Shovonlal

    Published in Heliyon (15-03-2024)
    “…Tuberculosis has been a challenge to the world since prehistoric times, and with the advent of drug-resistant strains, it has become more challenging to treat…”
    Get full text
    Journal Article
  8. 8

    Covalent drug – An emerging framework for targeted drug development by Bhole, Ritesh P., Joshi, Govinda O., Kapare, Harshad S., Chikhale, Rupesh V., Chaudhari, Somdatta

    Published in Results in Chemistry (01-06-2024)
    “…[Display omitted] •Historical overview traces covalent drugs since the 20th century, spotlighting safety concerns that hindered their…”
    Get full text
    Journal Article
  9. 9

    Determination and Pharmacokinetic Study of Pirfenidone in Rat Serum by High-Performance Thin-Layer Chromatography by Thorat, Sonali G., Chikhale, Rupesh V.

    Published in Journal of chromatographic science (01-08-2016)
    “…A rapid, sensitive and selective high-performance thin-layer chromatography (HPTLC) method was developed and validated for the determination and…”
    Get full text
    Journal Article
  10. 10

    Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy by Singh, Vibha, Bhoir, Siddhant, Chikhale, Rupesh V., Hussain, Javeena, Dwyer, Donard, Bryce, Richard A., Kirubakaran, Sivapriya, De Benedetti, Arrigo

    Published in iScience (25-09-2020)
    “…Through in vitro kinase assays and docking studies, we report the synthesis and biological evaluation of a phenothiazine analog J54 with potent TLK1 inhibitory…”
    Get full text
    Journal Article
  11. 11

    Design, synthesis and evaluation of novel enzalutamide analogues as potential anticancer agents by Bhole, Ritesh P., Chikhale, Rupesh V., Wavhale, Ravindra D., Asmary, Fatmah Ali, Almutairi, Tahani Mazyad, Alhajri, Hassna Mohammed, Bonde, Chandrakant G.

    Published in Heliyon (01-03-2021)
    “…The androgen receptor inhibitor, Enzalutamide, proved effective against castration resistance prostate cancer, has demonstrated clinical benefits and increased…”
    Get full text
    Journal Article
  12. 12

    Vitamin-anticancer drug conjugates: A new era for cancer therapy by Bhole,Ritesh, Jadhav,Shradha, Zambare,Yogesh, Chikhale,Rupesh V, Bonde,Chandrakant G

    Published in Istanbul journal of pharmacy (01-12-2020)
    “…Background: Following cardiovascular diseases, cancer is the world's second leading cause of death. Chemotherapy is the conventional gold technique for…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis by Chikhale, Rupesh V, Barmade, Mahesh A, Murumkar, Prashant R, Yadav, Mange Ram

    Published in Journal of medicinal chemistry (11-10-2018)
    “…Decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1), a vital enzyme for cell wall synthesis, plays a crucial role in the formation of lipoarabinomannan and…”
    Get full text
    Journal Article
  15. 15

    Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat Tuberculosis by Umare, Mohit D., Khedekar, Pramod B., Chikhale, Rupesh V.

    Published in ChemMedChem (15-10-2021)
    “…Tuberculosis is a prominent aliment throughout the world and a leading cause of mortality among infectious diseases. Drug development for multi‐drug resistance…”
    Get full text
    Journal Article
  16. 16

    Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery by Prasad, Mayuri S., Bhole, Ritesh P., Khedekar, Pramod B., Chikhale, Rupesh V.

    Published in Bioorganic chemistry (01-10-2021)
    “…[Display omitted] •InhA remains a novel target for development of antitubercular drugs.•High throughput screening and encoded library technology helped…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies by Chikhale, Rupesh V., Gupta, Vivek K., Eldesoky, Gaber E., Wabaidur, Saikh M., Patil, Shripad A., Islam, Md Ataul

    “…Recent outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a pandemic of COVID-19. The absence of a therapeutic drug and…”
    Get full text
    Journal Article
  19. 19

    Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach by Chikhale, Rupesh V., Gurav, Shailendra S., Patil, Rajesh B., Sinha, Saurabh K., Prasad, Satyendra K., Shakya, Anshul, Shrivastava, Sushant K., Gurav, Nilambari S., Prasad, Rupali S.

    “…COVID-19 has ravaged the world and is the greatest of pandemics in modern human history, in the absence of treatment or vaccine, the mortality and morbidity…”
    Get full text
    Journal Article
  20. 20